NCT00442221View on ClinicalTrials.gov

The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

August 31, 2004

Conditions
Migraine Headaches
Interventions
DRUG

Sumatriptan and Naproxen sodium

Trial Locations (2)

27401

Headache Wellness Center, Greensboro

27517

POZEN Inc., Chapel Hill

Sponsors

Lead Sponsor

POZEN
All Listed Sponsors
lead

POZEN

INDUSTRY

NCT00442221 - The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months | Biotech Hunter | Biotech Hunter